Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Knud Carsten Lønfeldt | M | 77 | 6 years | |
Marianne Weile Nonboe | F | 64 | 4 years | |
Thea Wulff Olesen | F | 58 | 8 years | |
Niels Tækker Foged | M | 63 | 6 years | |
Peter Morch Eriksen | M | 64 | 9 years | |
Carl Eistrup | M | - |
Zymenex A/S
Zymenex A/S BiotechnologyHealth Technology Zymenex A/S researches and develops therapeutics for life threatening diseases. The firm commercializes novel enzyme replacement therapies for the treatment of life-threatening, rare genetic diseases. The company was founded by Jens Fogh and Pär Gellerfors in 1998 and is headquartered in Hillerod, Denmark. | - |
Peter Nordkild | M | 69 | 6 years | |
Pia E. Ringholm | F | - |
Zymenex A/S
Zymenex A/S BiotechnologyHealth Technology Zymenex A/S researches and develops therapeutics for life threatening diseases. The firm commercializes novel enzyme replacement therapies for the treatment of life-threatening, rare genetic diseases. The company was founded by Jens Fogh and Pär Gellerfors in 1998 and is headquartered in Hillerod, Denmark. | - |
Fredric D. Price | M | 78 |
Zymenex A/S
Zymenex A/S BiotechnologyHealth Technology Zymenex A/S researches and develops therapeutics for life threatening diseases. The firm commercializes novel enzyme replacement therapies for the treatment of life-threatening, rare genetic diseases. The company was founded by Jens Fogh and Pär Gellerfors in 1998 and is headquartered in Hillerod, Denmark. | 1 years |
Finn Fjorder | M | - | 4 years | |
Laura von Kobyletzki | M | 53 | 1 years | |
Gry Louise Husby Larsen | F | - | 8 years | |
Roar Bjørk Seeger | M | 60 | - | |
Torben Arnth Nielsen | M | 64 | 8 years | |
Mikkel Dührkop | M | - |
Zymenex A/S
Zymenex A/S BiotechnologyHealth Technology Zymenex A/S researches and develops therapeutics for life threatening diseases. The firm commercializes novel enzyme replacement therapies for the treatment of life-threatening, rare genetic diseases. The company was founded by Jens Fogh and Pär Gellerfors in 1998 and is headquartered in Hillerod, Denmark. | - |
Claus Crone Fuglsang | M | 56 | 1 years | |
Thomas Magnussen | M | 71 | 8 years | |
Jan Honoré | M | - |
Zymenex A/S
Zymenex A/S BiotechnologyHealth Technology Zymenex A/S researches and develops therapeutics for life threatening diseases. The firm commercializes novel enzyme replacement therapies for the treatment of life-threatening, rare genetic diseases. The company was founded by Jens Fogh and Pär Gellerfors in 1998 and is headquartered in Hillerod, Denmark. | - |
Otto Rasmussen | M | - | 1 years |
Statistics
Country | Connections | % of total |
---|---|---|
Denmark | 19 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Frank Harder
- Personal Network